In a debate filmed at the 2015 SCTS Annual Meeting in Manchester, United Kingdom, Gilbert Massard and Gonzalo Varela offer different perspectives on how to best manage N2 disease. Gonzalo Varela of the Hospital Universitario de Salamanca, Salamanca, Spain, argues that clinical N2 disease precludes surgery, citing a lack of survival advantage and risk-effective therapy. Gilbert Massard of the Centre Hospitalier, Strasbourg, France, argues that surgery should be considered for N2 disease, citing improved survival after surgery.
Treatment of N2 NSCLC: A Plea for Surgery
N2 Disease Precludes Surgery
These presentations were originally given during the SCTS Ionescu University program at the 80th Annual Meeting of the Society for Cardiothoracic Surgery in Great Britain and Ireland. This content is published with the permission of SCTS. Please click here for information on the 2016 SCTS Annual Meeting.
